Hub partners, HeiQ and Xefco, have launched ground-breaking anti-viral face masks which can inactivate Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that has caused the COVID-19 pandemic, in as little as five minutes.
In a major research milestone for Xefco, HeiQ and our Research Hub, the masks will incorporate new patent-pending technology, called MetalliX™, invented by Xefco and further tested and refined with help from Hub researchers. The technology applies a world’s first thin-film antiviral copper treatment for textiles
Hub Chief Investigator A/Prof Alessandra Sutti explains: “The team provided scientific input and analysis of materials necessary for the scale-up from initial pilot trials to bulk production. We assisted in the characterisation of treated materials by co-designing, conducting and facilitating critical testing required for regulatory approval and to validate the safety of the materials.”
This outcome was a result of the industry partners and research team quickly pivoting their research focus as the pandemic hit in 2020. The team navigated a year of disrupted access to laboratories, lock-downs and travel restrictions to focus on bringing this new technology to the market rapidly.